Yangzhou Rixing Biotechnology Co., Ltd.

Yangzhou Rixing Biotechnology Co., Ltd. was founded in 1995, specializing in the production of pharmaceutical intermediates, and has a leading position in China. Located in Yangzhou City, only 3.5 hours' drive from Shanghai. rnMainly produce raw materials and finished products of glucosamine series, chondroitin sulfate series and chitosan series, such as tablets and capsules of various formulations. The annual output reaches 1800 tons. rnHave high-quality cooperative suppliers who can provide high-quality raw materials to ensure high-quality products. The products are widely sold in developed countries and regions in Europe, America and Japan, and enjoy a good reputation. rn company became a listed company on the New Third Board in 2015 (stock code: 835197). At present, our company has advanced production equipment, newly imported 42 reaction kettles, the volume is from 200L-8000L, all of which are designed according to the standard reaction, the reaction temperature is from minus 78°C to 150°C, equipped with 20 sets of water circulation vacuum pumps and 3 sets of Roots There are 2 sets of pumps and pressure kettles, which can do a pressure reaction of up to 20 kg. The company has a complete environmental protection and three-waste treatment system, and is the first batch of chemical monitoring point enterprises in Yangzhou. In 2015, our company successfully passed the certification of the National Standardization Management Committee as an AAAA standardization good behavior enterprise.

Visit Website

Manufacturer

Fan Jingni(CEO)

Glucosamine, Chondroitin Sulfate

Above 10M USD

101-500 people

10

Yangzhou Rixing Biotechnology Co., Ltd., founded in 1995 and located in Yangzhou City, Jiangsu Province, China, specializes in the production of pharmaceutical intermediates, particularly focusing on glucosamine, chondroitin sulfate, and chitosan. The company boasts a leading position in China's market and operates with advanced production facilities, including 42 reaction kettles ranging from 200L to 8000L in volume. These facilities are equipped to handle a wide range of chemical reactions under stringent standards, with capabilities from -78°C to 150°C and up to 20 kg pressure reactions. With an annual output of 1800 tons, Yangzhou Rixing Biotechnology ensures product quality through high-quality raw materials sourced from reliable suppliers. The company's products, including various formulations of tablets and capsules, are well-regarded and widely distributed in developed markets across Europe, America, and Japan. Yangzhou Rixing Biotechnology Co., Ltd. became a publicly listed company on the New Third Board in 2015 (stock code: 835197) and maintains a robust environmental protection and waste treatment system, recognized as one of Yangzhou's first batch of chemical monitoring point enterprises.